Chief, Medical Oncology MSKCC- Commack

Oncology

Dr. Philip Schulman, MD

Doctor Philip Schulman, MD practices Oncology. He studied medicine at State University of New York Upstate Medical University. Philip Schulman is a published MD. He published 2 publications, including: 'Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myel...'

Publications

Phase I trial of weekly and twice-weekly bortezomib with rituximab, cyclophosphamide, and prednisone in relapsed or refractory non-Hodgkin lymphoma.
Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myel...

Schools

SUNY Upstate Medical University Syracuse

Conditions Treated

Acute Leukemia
Adrenal Gland Cancer
Anal and Rectal Cancer
Anemia
View All

Doctors Specialties

Hematology
Medical Oncology
Oncology

Accepted Insurances

Education

North Shore-Long Island Jewish Health System
Memorial Sloan-Kettering Cancer Center
State University of New York Upstate Medical University

Hospital

Memorial Sloan-Kettering Cancer Center

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Jasmeet C. Singh, MD This Doctor is OpenDoctor Recommended.
	Dr. Jahan Aghalar, MD This Doctor is OpenDoctor Recommended.
	Dr. John J. Fiore, MD This Doctor is OpenDoctor Recommended.
	Dr. Steven Sugarman, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Stuart Lichtman, MD This Doctor is OpenDoctor Recommended. This doctor has more publications